Coma and respiratory arrest after exposure to butyrolactone.
A 2-year-old male was found unresponsive approximately 40 min after oral exposure to butyrolactone (Figure 1), a solvent used to remove methacrylate glues. The patient was apneic, bradycardic, and flaccid. He was given atropine and orally intubated, and his heart rate increased and blood pressure remained normal. He remained unresponsive to deep painful stimuli. Six hours after admission, the patient was alert and breathing spontaneously. He was extubated and discharged home the following day. Previous cases of serious toxicity following oral exposure to butyrolactone reported in Denmark have shown a similar propensity to bradycardia and coma. The use of butyrolactone is likely to increase, paralleling the popularity of acrylate adhesives. Emergency physicians should be aware of its potential for life-threatening toxicity.
Higgins
T F
TF
Department of Emergency Medicine, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio 44109-1998, USA.
Borron
S W
SW
D015107:4-Butyrolactone / Q000506:poisoning*; D000284:Administration, Oral; D002675:Child, Preschool; D003128:Coma / Q000139:chemically induced* / Q000628:therapy; D004349:Drug Packaging; D004632:Emergency Medical Services; D006801:Humans; D008297:Male; D012131:Respiratory Insufficiency / Q000139:chemically induced* / Q000628:therapy; D012997:Solvents / Q000506:poisoning*; D014481:United States
D012997:Solvents; D015107:4-Butyrolactone